45 results on '"Genina, A"'
Search Results
2. Impact of drug load and polymer molecular weight on the 3D microstructure of printed tablets
3. Mucoadhesive chitosan- and cellulose derivative-based nanofiber-on-foam-on-film system for non-invasive peptide delivery
4. Coating of Primary Powder Particles Improves the Quality of Binder Jetting 3D Printed Oral Solid Products
5. Chapter 11 - 3D printing in preclinical evaluation
6. Lessons to Learn for 3D Printing of Drug Products by Semisolid Extrusion (SSE)
7. Recent progress in tissue optical clearing for spectroscopic application
8. Hot Melt Extrusion as Solvent-Free Technique for a Continuous Manufacturing of Drug-Loaded Mesoporous Silica
9. Anti-tuberculosis drug combination for controlled oral delivery using 3D printed compartmental dosage forms: From drug product design to in vivo testing
10. Application of a colorimetric technique in quality control for printed pediatric orodispersible drug delivery systems containing propranolol hydrochloride
11. Three-Dimensional Printed PCL-Based Implantable Prototypes of Medical Devices for Controlled Drug Delivery
12. Quantification of caffeine and loperamide in printed formulations by infrared spectroscopy
13. Ethylene vinyl acetate (EVA) as a new drug carrier for 3D printed medical drug delivery devices
14. Fabrication of drug-loaded edible carrier substrates from nanosuspensions by flexographic printing
15. Improvement of dissolution rate of indomethacin by inkjet printing
16. Hyperspectral imaging in quality control of inkjet printed personalised dosage forms
17. Rizoma, an R&D&i Proposal in Education for Sustainability between Universities and Companies
18. The determinants of hepcidin level in chronic kidney disease and hemodialysis Saudi patients
19. Contributors
20. Tailored beads made of dissolved cellulose—Investigation of their drug release properties
21. Evaluation of different substrates for inkjet printing of rasagiline mesylate
22. A Step Toward Development of Printable Dosage Forms for Poorly Soluble Drugs
23. Behavior of printable formulations of loperamide and caffeine on different substrates—Effect of print density in inkjet printing
24. Tailoring controlled-release oral dosage forms by combining inkjet and flexographic printing techniques
25. A common pathway mediated through Toll-like receptors leads to T- and natural killer–cell immunosuppression
26. Measurement of Retinalamin diffusion coefficient in human sclera by optical spectroscopy
27. Effect of ethanol on the transport of methylene blue through stratum corneum
28. Chapter 12 - 3D printing in oral drug delivery
29. Optical properties of human stomach mucosa in the spectral range from 400 to 2000 nm: Prognosis for gastroenterology
30. Cryptopharmaceuticals: Increasing the Safety of Medication by a Blockchain of Pharmaceutical Products
31. Mesoporous carriers for transdermal delivery of antifungal drug
32. Roadmap to 3D-Printed Oral Pharmaceutical Dosage Forms: Feedstock Filament Properties and Characterization for Fused Deposition Modeling
33. INHIBITION OF WILMS TUMOR XENOGRAFT PROGRESSION BY HALOFUGINONE IS ACCOMPANIED BY ACTIVATION OF WT-1 GENE EXPRESSION
34. Halofuginone, an inhibitor of collagen synthesis by rat stellate cells, stimulates insulin-like growth factor binding protein-1 synthesis by hepatocytes
35. Chapter 5 - Gold Nanoparticle-Based Technologies in Photothermal/Photodynamic Treatment: The Challenges and Prospects
36. THE EFFECT OF HALOFUGINONE, AN INHIBITOR OF COLLAGEN TYPE I SYNTHESIS, ON URETHRAL STRICTURE FORMATION: IN VIVO AND IN VITRO STUDY IN A RAT MODEL
37. Contributors
38. Towards fabrication of 3D printed medical devices to prevent biofilm formation
39. List of Contributors
40. Printing medicine: New technique and its impact on society
41. Corrigendum to “The determinants of hepcidin level in chronic kidney disease and hemodialysis Saudi patients” [Beni-Suef Univ J Basic Appl Sci 3 (2) (June 2014) 133–139]
42. Arrangement for study of π0-photoproduction on 4He nuclei
43. Halofuginone, a specific inhibitor of collagen type I synthesis, prevents dimethylnitrosamine-induced liver cirrhosis
44. Inhibition of glomerular mesangial cell proliferation and extracellular matrix deposition by halofuginone
45. Inhibition of collagen type I synthesis by skin fibroblasts of graft versus host disease and scleroderma patients: Effect of halofuginone
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.